51 – 60 of 1421
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Strong diagnostic performance of plasma ptau217 for CSF biomarker-defined young-onset Alzheimer disease in a diagnostically heterogeneous clinical cohort
(
- Contribution to journal › Article
-
Mark
APOE4 impact on soluble and insoluble tau pathology is mostly influenced by amyloid-beta
2025) In Brain : a journal of neurology(
- Contribution to journal › Article
-
Mark
GBA1 T369M and Parkinson's disease - Further evidence of a lack of association in the Swedish population
(
- Contribution to journal › Article
-
Mark
Degree of amyloid-β burden could be indicative of the primary etiology underlying dementia
(
- Contribution to journal › Article
-
Mark
Balance and gait disorders in de novo Parkinson’s disease : support for early rehabilitation
(
- Contribution to journal › Article
-
Mark
Associations between structural brain changes and blood neurofilament light chain protein in treatment-resistant schizophrenia
2025) In Australian and New Zealand Journal of Psychiatry(
- Contribution to journal › Article
-
Mark
The impact of disease activity and interferon-α on the nervous system in systemic lupus erythematosus
(
- Contribution to journal › Article
-
Mark
Health-promoting text messages to patients with hypertension—A randomized controlled trial in Swedish primary healthcare
(
- Contribution to journal › Article
-
Mark
Neurocognition, Cerebellar Functions and Psychiatric Features in Spinocerebellar Ataxia Type 34
(
- Contribution to journal › Published meeting abstract
-
Mark
Machine learning prediction of tau-PET in Alzheimer's disease using plasma, MRI, and clinical data
(
- Contribution to journal › Article